Higher stem cell dose infusion after intensive chemotherapy does not improve symptom burden in older patients with multiple myeloma and amyloidosis

Autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma (MM) is associated with high symptom burden, particularly for older patients and those with amyloid light-chain (AL) amyloidosis. Symptom burden peaks during leukopenia. We hypothesized that higher doses of CD34(+) stem c...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biol Blood Marrow Transplant
Auteurs principaux: Shah, Nina, Shi, Qiuling, Williams, Loretta A., Mendoza, Tito R., Wang, Xin Shelley, Reuben, James M., Dougherty, Patrick M., Bashir, Qaiser, Qazilbash, Muzaffar H., Champlin, Richard E., Cleeland, Charles S., Giralt, Sergio A.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716870/
https://ncbi.nlm.nih.gov/pubmed/26253006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.07.036
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires